NeueHealth (NYSE:NEUE – Get Free Report) is anticipated to announce its earnings results before the market opens on Wednesday, March 5th. Analysts expect the company to announce earnings of ($2.29) per share and revenue of $261.80 million for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.
NeueHealth Stock Performance
NYSE NEUE opened at $7.31 on Tuesday. The stock has a market capitalization of $60.56 million, a P/E ratio of -0.14 and a beta of 0.58. The business’s fifty day moving average is $7.36 and its two-hundred day moving average is $5.90. NeueHealth has a 1 year low of $3.79 and a 1 year high of $11.35.
Insider Activity at NeueHealth
In related news, CEO George Lawrence Mikan III sold 16,803 shares of the firm’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $4.18, for a total value of $70,236.54. Following the transaction, the chief executive officer now directly owns 83,029 shares in the company, valued at approximately $347,061.22. This trade represents a 16.83 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Jay Matushak sold 4,970 shares of the firm’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $36,430.10. Following the completion of the sale, the chief financial officer now directly owns 17,747 shares in the company, valued at approximately $130,085.51. This represents a 21.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 58,658 shares of company stock valued at $377,034. 64.30% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on NeueHealth
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
- Five stocks we like better than NeueHealth
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is the Hang Seng index?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What is the Dow Jones Industrial Average (DJIA)?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.